Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-29 · accession 0001104659-24-030156 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-01 | 2024-02-29+ | PTGX | Ali Asif | CFO | S - Sale+OE | $31.60 | -24.2K | 42.7K | -36% | -$764.4K |
| D | 2024-03-01 | 2024-03-01 | PTGX | Ali Asif | CFO | M - OptEx | $12.17 | +12.0K | 52.6K | +30% | +$146.0K |
| D | 2024-03-01 | 2024-03-01 | PTGX | Ali Asif | CFO | M - OptEx | $0.00 | -12.0K | 51.8K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | S | D | 2,248 | $32.33 | 38,397 | D | — | — | (F3) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $32.28 to $32.39. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-02-29 | S | D | 2,089 | $31.00 | 40,645 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-01 | S | D | 12,000 | $32.22 | 40,645 | D | — | — | (F2) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $32.17 to $32.31. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-03-01 | M | A | 12,000 | $12.17 | 52,645 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-29 | S | D | 7,850 | $30.61 | 42,734 | D | — | — | (F1) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $30.57 to $30.76. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | Stock Option (right to buy) | 2024-03-01 | M | D | 12,000 | $0.00 | 51,750 | D | $12.17 · — to 2033-01-15 | 12,000 Common Stock | (F4) The stock option was granted to the Reporting Person on January 16, 2023 and vests in 48 equal monthly installments following the date of grant. |